Delivery time is 3-4 weeks on this product. Faster delivery is available (1 week) but there will be an additional freight cost of $150.
Product Description
Mycoplasma Removal Agent (MRA) is a highly effective solution for the serious problem of mycoplasma contamination in cell cultures. MRA is a derivative of the quinoline family of antibiotics and eliminates mycoplasma infection by inhibiting mycoplasma DNA gyrase. MRA is supplied as a ready-to-use solution and each vial can decontaminate up to 25 cell cultures. MRA has been cited by the European Collection of Animal Cell Cultures (Porton Down, U.K.) as being superior to all other current products for the eradication of mycoplasma. Cell toxicity is low following treatment at the recommended concentration of 0.5 µg/mL, as is regrowth of mycoplasma after cellular transfer.
- Eliminate multiple mycoplasma species within one week using the lowest dosage
- Prevent recontamination of the culture at 0.1 µg/mL
- Maintain cell viability
- Compatible with most mammalian cell lines
- Sterility and low cytotoxicity
- Cited and recognized in 550+ scientific publications
Application Notes
Mycoplasma Removal Agent (MRA) eliminates mycoplasma contamination from cell cultures. The cytotoxicity of MRA is low and cell toxicity is rare when used at the recommended concentration. For specific function of any cell it is recommended that the retention of desired cellular characteristics be confirmed after treatment.
Usage Statement
Research Use Only (RUO). Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Key Applications
Elimination of mycoplasma contamination from cell cultures
